Sepsis (blood poisoning) is a serious disease, for which there are no approved drugs. The purpose of this project is to make it possible to evaluate the protein p33 as a new treatment for sepsis. The plan is to apply for a patent on protein p33 and do additional studies in order to allow a commercial development of the compound for future drugs.